Type to search

Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline | Pharmtech Focus
Aristea Appoints Justin Thacker as Chief Financial Officer | Pharmtech Focus
Aristea Completes $63 Million Series B Financing to Accelerate Clinical Development of Novel Immunotherapy Drugs for the Treatment of Orphan Diseases | Pharmtech Focus